ResearcherUniversity Hospital MünsterNo recent work listed

Max M. Träger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1987-4798; OpenAlex author ID A5034361015. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 2 papers

Papers 2

The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-018-2755-9 ↗
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers10090328 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Konrad Steinestel · 2 shared papers, 2018 · strength 0.18
- Paper The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-018-2755-9 ↗
- Paper Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers10090328 ↗
Norbert J. Senninger · 2 shared papers, 2018 · strength 0.18
- Paper The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-018-2755-9 ↗
- Paper Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers10090328 ↗
Sameer Abdallah Dhayat · 2 shared papers, 2018 · strength 0.18
- Paper The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma. DOI 10.1007/s00432-018-2755-9 ↗
- Paper Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers10090328 ↗
Anda Ströse · 1 shared paper, 2018 · strength 0.09
- Paper Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers10090328 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.